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Renal cortical drug and xenobiotic metabolism following urinary tract
obstruction. Renal cortical metabolism of drugs and xenobiotics was
assessed with microsomes prepared from normal, contralateral and 4-
day postobstructive hydronephrotic kidneys. Microsomal mixed-func-
tion oxidase and prostaglandin H synthase systems were determined in
control and 3-methylcholanthrene-treated rabbits. Cytochrome P450
content and biphenyl-4-hydroxylase activity but not cytochrome c
reductase activity were reduced in the hydronephrotic kidney. 3-
Methylcholanthrene treatment increased cytochrome P450 content and
biphenyl-4-hydroxylase and acetanilide-4-hydroxylase activities in nor-
mal, contralateral, and hydronephrotic kidneys. However, even after 3-
methylcholanthrene treatment, hydronephrotic kidney cytochrome
P450 content and acetanilide-4-hydroxylase activity were not more than
20% of the corresponding normal kidney values. Prostaglandin H
synthase metabolism of benzidine was observed in the hydronephrotic
kidney but was at the limit of detection in normal or contralateral
kidneys with or without 3-methylcholanthrene treatment. Characteris-
tics of benzidine metabolism were consistent with the hydroperoxidase
rather than the fatty acid cyclooxygenase activity of prostaglandin H
synthase. Therefore, hydronephrosis alters the drug and xenobiotic
metabolic profile of the renal cortex from a primarily mixed-function
oxidase-dependent system to one with the potential for metabolism by
the hydroperoxidase component of prostaglandin H synthase.
Métabolisme cortical renal des medicaments et xenobiotiques après
obstruction du tractus urinaire. Le métabolisme cortical renal de
médicaments et de xenobiotiques a etC CtudiC avec des microsomes
prCparés a partir des reins normaux, controlatérals, et hydronephroti-
ques, 4 jours après une obstruction. Les systèmes microsomiaux de
fonction oxydase mixte et de prostaglandine H synthétase ont Cté
déterminés chez des lapins contrôles et traitCs par du 3-méthylcholan-
thrène. Le contenu en cytochrome P450 et l'activité biphenyl-4-hydrox-
ylase, mais non l'activité cytochrome c réductase Ctaient diminués dans
Ic rein hydronephrotique. Le traitement par Ic 3-methylcholanthrène a
augmentC Ic contenu en cytochrome P450 et les activités biphényl-4-
hydroxylase et acétanilide-4-hydroxylase chez les reins normaux, con-
trolatérals et hydronephrotiques. Cependant, méme apres traitement
par le 3-methylcholanthrene, Ic contenu en cytochrome P450 du rein
hydronéphrotique et son activitC acetanilide-4-hydroxylase n'Ctaient
pas de plus de 20% des valeurs dans le rein normaux correspondant. Le
mCtabolisme de Ia benzidine par Ia prostaglandine H synthetase était
observable dans le rein hydronephrotique, mais était a Ia limite de Ia
detection dans les reins normaux ou controlatérals, avec ou sans
traitement par Ic 3-methylcholanthrene. Les caractéristiques du méta-
bolisme de Ia benzidine étaient plus compatibles avec l'activité hydro-
peroxidase qu'avec l'activité cyclooxygenase des acides gras de Ia
prostaglandine H synthétase. Ainsi, l'hydronephrose altére le profil
métabolique des drogues et des xénobiotiques dans le cortex renal d'un
système primitivement dCpendant d'une fonction oxydase mixte a un
système ayant Ia capacité de métabolisme par le constituant hydroper-
oxydase de Ia prostaglandine H synthetase.
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Nephrotoxic reactions account for a large proportion of both
acute and chronic renal failures [1—3]. Renal metabolism of
drugs and xenobiotics is thought to play an important role in
nephrotoxic reactions which require metabolic activation of the
parent compound [4, 5. An example is acetaminophen, which
is thought to undergo metabolic activation to elicit its nephro-
toxic effects [4, 5]. Oxidative metabolism is a potentially
important mechanism for the activation of drugs and xenobiot-
ics to more active toxins and ultimate carcinogens. Previous
studies demonstrate two separate pathways for microsomal
oxidative metabolism of drugs and xenobiotics in the normal
kidney; these two mechanisms exhibit an anatomical separation
within the kidney. The cytochrome P450 mixed-function oxi-
dase system predominates in the renal cortex while cooxidation
by the hydroperoxidase component of prostaglandin H syn-
thase (PHS) predominates in the renal inner medulla [6—8]. PHS
has been shown to metabolize drugs and xenobiotics in intact
renal cells [9] and in the whole kidney [10].
Urinary tract obstruction is a common clinical problem and is
frequently a cause of tubule-interstitial nephritis [11]. In the
rabbit, 4 days of ureteral obstruction have been associated with
an exaggerated rate of prostaglandin production by the renal
cortex, which can be correlated with an increased rate of
synthesis of PHS by the ureteral obstructed kidney [12]. The
contralateral kidney undergoes increased new protein synthesis
associated with compensatory hypertrophy, but there is no
evidence that its prostaglandin production increases. The pur-
pose of these experiments is to assess the effect of ureteral
obstruction and compensatory hypertrophy on oxidative drug
metabolism in cortical microsomes prepared from 4-day postob-
structive hydronephrotic (HNK), contralateral (CLK), and
normal kidneys (NK).
Methods
Materials. [N-5,6,8,9,l l,12,l4,l5-3H]Arachidonic acid (78.2
Ci/mmole), and [U-'4C]benzidine (25.7 mCi/mmole) were pur-
chased from New England Nuclear Corp., Boston, Massachu-
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setts. Acetanilide (ring-UL-'4C) (10.5 mCi/mmole) came from
California Bionuclear, Sun Valley, California, Scintillation fluid
(ACS) was from Amersham, Arlington Heights, Illinois. Nu
Chek Prep, Inc., Elysian, Minnesota, supplied the 5,8,11,14-
eicosatetraenoic acid (arachidonic acid). Biphenyl and acetyl-
salicylic acid (aspirin) were purchased from Aldrich Chemical
Co., Milwaukee, Wisconsin, 4-hydroxylbiphenyl (p-phenyl-
phenol), acetanilide and 3-methyicholanthrene (3-MC) from
Eastman Kodak, Rochester, New York, and acetaminophen
(4'-hydroxyacetanilide) from Mallinckrodt, Raleigh, North Car-
olina. Glucose 6-phosphate (disodium salt), glucose 6-phos-
phate dehydrogenase (type IV), NADP, NADPH, cytochrome
c (type III), dithiothreitol, bovine serum albumin, indometh-
acm benzidine dihydrochioride, reduced glutathione, 11,14,17-
eicosatrienoic acid, 9,12,15-octadecatrienoic acid, sodium salic-
ylate and metyrapone were purchased from Sigma Chemical
Co., St. Louis, Missouri. 15-HPETE was synthetized as previ-
ously described [13]. PGE2 was a generous gift of The Upjohn
Co., Kalamazoo, Michigan. Thin-layer chromatographic plates
(Silica Gel F254) were obtained from EM Laboratories, Inc.,
Elmsford, New York. All other chemicals were purchased in
the highest possible grade from standard sources.
Animals and treatment. New Zealand White male rabbits
weighing 1.5 to 2.0 kg were purchased from Eldridge Labora-
tory Animals, Barnhart, Missouri, housed in a controlled envi-
ronment and allowed free access to food and water. Complete
ureteral obstruction was produced by tying a suture around the
left ureter of sodium thiopental anesthetized rabbits. Control
and hydronephrotic rabbits were injected with either corn oil or
3-MC, 40 mg/kg in corn oil, i.p., once daily for 3 days [6].
Preparation of microsomes. After an overnight fast, control
and 4-day ureter-obstructed rabbits were anesthetized with
sodium thiopental, 20 mg/kg i.v. [6]. Kidneys and livers were
quickly removed and placed in ice-cold 0.9% NaCI, The renal
cortex and medulla were separated by careful dissection. Tissue
was minced, washed free of hemoglobin, and homogenized with
three 15-sec bursts at 30-sec intervals using a Polytron homoge-
nizer in 3 volumes of 0.1 M phosphate buffer (pH 7.8) containing
20% glycerol and iO M dithiothreitol. The homogenate was
centrifuged at x l0,000g for 15 mm and the subsequent superna-
tant at x lOO,000g for 60 mm. Pellets were resuspended in 1.15%
KCI and centrifuged at X l05,000g for 60 mm. Microsomal
pellets were resuspended in 0.1 M phosphate buffer (pH 7.8) and
were stored at —80°C. Protein content was estimated by Low-
ry's method [14] using bovine serum albumin as a standard.
Cytochrome P450 content. Microsomal cytochrome P450
content was determined by the method of Omura and Sato [IS].
An extinction coefficient of 91 mM cm for the carbon
monoxide difference spectrum of reduced microsomes (E450-
E4) was used.
Bipheny!-4-hydroxylase activity. Enzyme activity was deter-
mined by the method of Creaven, Parke, and Williams [161 as
modified by Atlas and Nebert [17]. Assays were done at a
microsomal protein concentration of 3.0 mg/mI and results are
expressed as picomoles of 4-hydroxybiphenyl produced per
minute per milligrams of microsomal protein. Blank values (no
regenerating system) were subtracted from all samples. Fluo-
rescent measurements were performed with spectrophotofluor-
ometer (Model J4-8960, Aminco-Bowman, Silver Springs,
Maryland) with 1 cm2 quartz cuvettes, and a xenon lamp light
source. Excitation and emission wavelengths were 311 and 400
nm, respectively, and were uncorrected instrumental values.
Because previous studies have demonstrated that biphenyl-2-
hydroxylase activity is negligible in rabbit kidney microsomes
[18], only biphenyl-4-hydroxylase activity was determined.
Acetanilide hydroxylase activity. Enzyme activity was mea-
sured according to Daly [19] and Atlas and Nebert [17] with the
following modifications: Total reaction volume of 0.1 ml con-
tained 0.25 mM '4C-acetanilide, 0.65 mg microsomal protein,
and a regenerating system consisting of 8.75 mM glucose-6-
phosphate, 0.75 mivi NADP, and 0.0125 U glucose-6-phosphate
dehydrogenase. Reaction was stopped with 0.01 ml 2 M citric
acid, and 3 mrvi 4'-hydroxyacetanilide. Samples were extracted
twice with 1 ml of ethyl acetate, dried with sodium sulfate, and
evaporated to dryness under N2. Residues were dissolved in
0.05 ml acetone and applied to thin-layer chromatographic
plates. Rf's for acetanilide and 4'-hydroxyacetanilide were 0.34
and 0.11, respectively. After ultraviolet visualization, spots
were scraped into scintillation vials; the radioactivity was
assessed with a liquid scintillation counter (Beckman 6800,
Beckman Instruments, Fullerton, California). Hydroxylase ac-
tivity was completely inhibited by metyrapone. Blank values
(no regenerating system) were subtracted from all samples.
Results are expressed as picomoles of 4'-hydroxyacetanilide
produced per minute per milligram of microsomal protein.
Cytochrome c reductase activity. Enzyme activity was as-
sayed according to Williams and Kamin [201, using a molar
absorbancy index of 21.0 x 106 cm2 mole [21].
Determination of '4C-benzidine binding. Reaction mixtures
contained 0.5 to 0.9 mg/mI microsomal protein, 0.1 M phosphate
buffer (pH 7.8), 0.07 m'vi '4C-benzidine, either 0.1 mM arachi-
donic acid or other substrates as indicated, and various inhibi-
tors in a final volume of 0.1 ml [22]. Inhibitors were preincubat-
ed with microsomes for 5 mm at room temperature. Incubations
at 37°C for 10 mm were started by the addition of substrate. The
reaction was stopped by the addition of unlabeled benzidine to a
concentration of 0.75 mi, followed by I ml of ethyl acetate, as
previously described [22]. The organic layer was removed after
centrifugation at x 1 ,500g for 10 mm. Following three ethyl
acetate extractions, the aqueous phase was adjusted to 0.3 M
TCA and centrifuged at x2,500g for 10 mm. The aqueous layer
was saved, and the resulting precipitate was washed with I ml
of 0.3 M TCA followed by centrifugation until the radioactivity
of the supernatant was similar to the background. The original
aqueous layer was combined with subsequent washes and the
radioactivity was assessed to determine aqueous, non-TCA-
precipitable metabolism, The pellet was dissolved in 0.4 ml of 1
N NaOH at 60°C for 30 mm, diluted to 0.8 ml with distilled
water, aliquoted, and analyzed for aqueous TCA-precipitable
material. Blank values were obtained with heated microsomes
and were not different from samples incubated without arachi-
donic acid. Blank values were subtracted from experimental
values. Metabolism is expressed as pmoles/mg protein/mm.
Metabolism of 3H-arachidonic acid. Reaction mixtures con-
tained 0.3 to 0.6 mg/mI microsomal protein, 0.1 M phosphate
buffer (pH 7.8), 1.0 mrs'i glutathione, and 0.1 mii 3H-arachidonic
acid in a final volume of 0.1 ml [23]. The reaction was started by
the addition of arachidonic acid, incubated at 37°C for 10 mm
and stopped by the addition of hydrochloric acid. Samples
adjusted to pH 3 to 3.5 were extracted with ethyl acetate and
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Fig. 1. Cyiochrome P450 spectra of microsomes prepared from normal
(A), contralateral (B), and hydronephrotic (C) kidney cortex. Difference
spectra were obtained with dithionite-reduced, carbon monoxide-treat-
ed microsomes.
evaporated to dryness under nitrogen gas. Samples were ap-
plied to silica gel F254 plates and developed with a solvent
system containing chloroform:methanol:acetic acid (90:5:5).
Radioactivity was determined with a radiochromatogram scan-
ner (Series 7320, Packard Instruments, United Technology,
Downers Grove, Illinois). Arachidonic acid and prostaglandin
standards were visualized with iodine vapors.
Results
Cytochrome P450 difference spectra of cortical microsomes
prepared from NK, CLK, and HNK are illustrated in Figure 1.
NK and CLK spectra were similar. The difference spectrum
observed with HNK was at the limit of detection, even when
measured at 5 mg/mI of microsomal protein.
To further assess differences in the renal cortical mixed-
function oxidase system, normal and hydronephrotic rabbits
were treated with 3-MC (Table 1). 3-MC treatment elicited a
significant increase in cytochrome P450 content in NK, CLK,
and HNK. However, the cytochrome P450 content in HNK
cortex, even after 3-MC was still barely detectible. Cytochrome
c reductase, another component of the mixed-function oxidase
system, was similar in NK, CLK, and HNK cortex with control
or 3-MC-treated rabbits.
The mixed-function oxidase enzymes biphenyl-4-hydroxy-
lase and acetanilide hydroxylase were also evaluated (Table 1).
There was approximately three times as much biphenyl-4-
hydroxylase activity in NK or CLK compared to HNK. Fol-
lowing 3-MC treatment, enzymatic activity increased in all
three tissues to the extent that the rate of biphenyl metabolism
was similar in NK, CLK, and HNK. Acetanilide hydroxylase
activity was only observed following 3-MC treatment; this
activity in HNK was approximately 20% that observed in NK.
The prostaglandin H synthase system was assessed as an
alternative pathway for the renal cortical metabolism of drugs
and xenobiotics (Fig. 2). Prostaglandin H synthase activates
benzidine to a cation-free radical intermediate, which binds
nucleophilic sites on protein and nucleic acids [24]. Therefore,
the binding of benzidine to protein is an index of metabolism by
prostaglandin H synthase. Benzidine binding to TCA-precipita-
ble material was at the limit of detection with NK or CLK
microsomes. Significant binding was observed in HNK with or
without 3-MC treatment. Requirements for benzidine binding
with HNK microsomes were further investigated (Table 2).
Arachidonic acid elicited a dose-dependent increase in benzi-
dine metabolism. Neither 11,14,1 7-eicosatrienoic acid, 9,12,15-
octadecatrienoic acid, PGE2, or NADPH elicited metabolism of
benzidine, while metabolism was observed with 15-HPETE.
Arachidonic acid-mediated metabolism was inhibited by aspi-
rin, indomethacin, and meclofenamic acid but not by salicylate
or metyrapone. Glutathione increased the ratio of aqueous non-
TCA-precipitable to aqueous TCA-precipitable material. Ara-
chidonic acid metabolism by cortical microsomes prepared
from HNK and CLK was determined (Fig. 3). Significant
metabolism of arachidonic acid was observed with HNK but
not CLK microsomes.
Discussion
These results indicate specific differences in the profiles of
oxidative drug and xenobiotic metabolism between renal corti-
cal microsomes prepared from HNK and either CLK or NK.
There was a loss of cytochrome P450 content and biphenyl-4-
hydroxylase activity in the hydronephrotic cortex. Microsomal
cytochrome creductase activity was similar in all three prepara-
tions. Because the synthesis and degradation of cytochrome
P450 and hydroxylases are through a different pathway than
cytochrome c reductase, the reduction of the former but not the
latter during hydronephrosis suggests that the loss in activity
was not due to reduced recovery of microsomes. Therefore, 4-
day unilateral ureter obstruction reduces the capacity of the
kidney to metabolize drugs and xenobiotics by the microsomal
mixed-function oxidase system.
There was less renal mixed-function oxidase activity in the
HNK compared to NK or CLK even after 3-MC treatment.
However, biphenyl-4-hydroxylase activity was similar in NK,
HNK, and CLK after 3-MC treatment. Both cytochrome P450
content and acetanilide-4-hydroxylase in HNK were increased
by 3-MC but neither parameter was more than 20% of the
corresponding values in NK. The reason for this differential
effect of 3-MC is not entirely clear. The mixed-function oxidase
B
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Table 1. Renal cortical cytochrome P450 content, NADPH-cytochrome c reductase and mixed-function oxidase activities from control and 3-
methyicholanthrene-treated rabbitsa
Type of kidney
Cytochrome P450 contentb
NADPH-cytochrome
c reductasec
Control Treated
Biphenyl-4-
hydroxylased
Acetanilide
hydroxylase
Control Treated Control Treated Control Treated
Normal 0.09 0.01 0.15 0.01 25 2 18 2 II 1 25 2 ND 23 2
Hydronephrotic ND 0.03 0.004 23 3 27 2 3 0.5 29 3 ND 5 1
Contralateral 0.06 0.004 0.16 0.01 27 1 26 2 10 I 31 3 ND 30 3
Abbreviation: ND, not detectable.
a The values represent mean SE; N = 3 to 4.
b The values represent nanomoles of cytochrome P450 per milligram of microsomal protein.
The values represent micromoles of cytochrome c reduced per milligram of microsomal protein per minute.
The values represent picomoles of 4-hydroxybiphenyl formed per milligram of microsomal protein per minute.
The values represent picomoles of 4'-hydroxyacetanilide formed per milligram of microsomal protein per minute.
Fig. 2. Arachidonic acid-dependent metabolism of '4C-benzidine by
cortical microsomes prepared from control and 3-methyicholan-
threne-treated • rabbits.
system is not uniformly distributed within the renal cortex, but
rather appears to be primarily located in the S2 and S3 segments
of the proximal tubule [25, 26] and, to a lesser extent, in the
renal endothelium [25]. In addition, the distribution of cyto-
chrome P450 isozymes appears to be unique, with Forms 2 and
3 localized in the proximal tubule and Forms 4 and 6 in the renal
endothelium [251. This differential distribution could explain
why there is a differential response to 3-MC treatment if certain
cells are damaged more than others by hydronephrosis.
Increased synthesis of prostaglandins is a unique characteris-
tic of the HNK and has been correlated with increased synthe-
sis of PHS. Increased prostaglandin synthesis is not observed in
renal medullary tissue following unilateral obstruction. In-
creased cortical prostaglandin synthesis has been associated
with increased proliferation and/or infiltration of fibroblasts and
macrophages within the renal cortex [27]. As shown in Figure 3,
the HNK synthesizes significantly more prostaglandins and
thromboxanes from arachidonic acid than CLK.
The prostaglandin hydroperoxidase activity of PHS is re-
sponsible for the metabolism of certain drugs and xenobiotics.
In view of the decreased mixed-function oxidase activity and
the increased rate of prostaglandin synthesis observed in the
HNK, the PHS system was assessed and compared to the
mixed-function oxidase system. Benzidine was metabolized by
HNK cortex but was at the limit of detection in NK or CLK.
Benzidine metabolism was initiated by specific fatty acid sub-
strates, arachidonic acid [28], and was prevented by specific
Aqueous, Aqueous,
TCA non-TCA
Concen- precipitabletration
Additions mt N pmoles/mg
precipitable
protein/mm
Experiment 1'
None 7 ND ND
Arachidonic acid 0.1
0.05
7
4
94 4
51± 5
27 I
16±1
11,14, 17-Eicosatrienoic
acid 0.1 4 9± 1 ND
9,12, 15-Octadecatri-
enoic acid 0.1 3 ND ND
PGE2 0.1 3 ND ND
NADPH 1.0 3 ND ND
15-HPETE 0.05 4 90 4 23 2
Experiment 2
Arachidonic acid 0.15 7 120 8 11 I
+ Aspirin 2.0 4 2 0.6 ND
+ Salicylate 2.0 4 116 20 ND
+ Indomethacin 0.1 3 ND ND
+ Meclofenamic acid 0.15 4 ND ND
+ Metyrapone 1.0 3 136 14 23 3
+ Glutathjone 1.0 3 16 1 74 5
inhibitors of PHS, that is, aspirin, indomethacin, and meclofen-
amic acid [29]. Salicylate, the deacetylated aspirin analogue,
and metyrapone, a mixed-function oxidase inhibitor, did not
alter arachidonic acid-dependent metabolism of benzidine. Ef-
fects of glutathione were consistent with previous studies which
suggested the formation of a glutathione-benzidine conjugate
[22]. Glutathione is thought to be important in the in vivo
inactivation of renal toxins [4, 5]. The 15-hydroperoxy analogue
of arachidonic acid (15-HPETE) initiated benzidine metabolism
which was not inhibited by aspirin (not shown). These results
are consistent with the hydroperoxidase rather than the fatty
cyclooxygenase activity of PHS catalyzing the metabolism of
benzidine in HNK.
C
E
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Table 2. Requirements for benzidine metabolism by microsomes
prepared from control hydronephrotic kidney cortexa
20
Normal Hydronephrotic
I
Contralateral
Abbreviations: ND, not detected; N, number of experiments.
a The incubations contained microsomal protein, 0.1 M phosphate
buffer, 0.09 mri benzidine, and 0.0012 mi methemoglobin.
b In experiment I, reactions were initiated by the addition of the
indicated substrate.
In experiment 2, test agents were preincubated with reaction
mixtures for 2 mm before the addition of the arachidonic acid substrate.
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Fig. 3. Thin-layer chromatographic radioscan of 3H-arachidonic acid
metabolism by microsomes prepared from hydronephrotic (A) and
contralateral (B) kidney.
PHS-catalyzed metabolism of benzidine, a nephrotoxin and
urinary tract carcinogen [30], may be a unique characteristic of
this enzyme. Benzidine is not metabolized by the mixed-
function oxidase system but this enzyme system will metabolize
the acetylated derivatives of benzidine [31, 32]. PHS has been
shown to activate benzidine to a cation-free radical which binds
tissue nucleophiles such as protein, t-RNA, and DNA [24, 331.
Nephrotoxins and renal carcinogens are thought to elicit their
toxic effects by binding such nucleophiles. Several other uri-
nary tract carcinogens and nephrotoxins besides benzidine are
metabolized by PHS. These include acetaminophen [23, 34, 35],
3-hydroxymethyl -I- [(3-(5-nitro-2-furyl)-allydidene)amino]-hy-
dantoin [36], diethylstilbestrol [8], 2-naphthylamine [37], 4-
aminobiphenyl [37], 2-aminofluorene [37], and p-phenetidine
[37]. Except for 3-hydroxymethyl- 1 -[(3-(5-nitro-2-furyl)-allydi-
dene)amino]-hydantoin, all these compounds have been shown
to be activated by PHS to bind tissue nucleophiles. Immunohis-
tofluorescence studies of subcellular localization have demon-
strated that PHS is associated with the endoplasmic reticulum
and nuclear membrane [381. This subcellular localization would
make both the cytoplasm and nucleus of cells susceptible to
cooxidative damage.
Hydronephrosis alters the drug and xenobiotic metabolic
profile of the renal cortex. A model describing these alterations
is illustrated in Figure 4. Three categories of compounds are
envisioned: one in which metabolism only occurs by PHS (that
is, benzidine), a second in which both PHS and mixed-function
oxidase are metabolically active (that is, acetaminophen), and a
third in which only mixed-function oxidase is active (that is,
biphenyl). It has been recently shown that acetaminophen is
metabolized by both the mixed-function oxidase and PHS
systems [4, 35]. In contrast, biphenyl is metabolized by the
mixed-function oxidase system [16, 17] but not by PHS (not
shown). In NK and CLK, drugs and xenobiotics can only be
metabolized by the mixed-function oxidase system (categories 2
and 3). In HNK, drugs and xenobiotics can be metabolized by
both the mixed-function oxidase and PHS systems (categories
1, 2, and 3). However, metabolism by the mixed-function
oxidase system in HNK is significantly reduced. 3-MC treat-
ment can restore a certain amount of the latter. The HNK is
capable of metabolizing certain chemicals not possible in the
NK or CLK. Nephrotoxicity is thought to be initiated by the
metabolic formation of activated compounds which bind tissue
nucleophiles. Alteration of the drug and xenobiotic metabolic
profile in HNK may have profound effects on renal cortical
function and may contribute to the progressive deterioration
observed in hydronephrosis.
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